Nov 11, 2026 · Science & Research Daily Digest
Science, space, biomedicine, and climate research highlights compiled for November 11, 2026, with summaries, links, and commentary.
I. Space & Deep Space
1. ESA’s Hera arrives at Didymos and begins “rectangular-orbit” early characterisation (planetary defence)
Summary:
On November 11, ESA reported that its planetary-defence mission Hera has arrived at the Didymos binary asteroid system, holding roughly 25–30 km from the pair and starting early characterisation. Primary Didymos is about 780 m across; moonlet Dimorphos about 151 m. In such weak gravity, Hera flies near-straight segments at only ~12 cm/s and fires thrusters every three then four days to turn 90°, tracing “rectangular orbits.” NASA’s DART struck Dimorphos at ~6.1 km/s in 2022 and shortened its orbit by about 33 minutes; Hera will now test which impact-model forecasts match reality. Next month the craft is to move to ~20 km for detailed characterisation and later deploy two CubeSats.
Links:
- ESA — Hera spacecraft in rectangular orbit around target asteroids
- BBC Sky at Night — Hera first close-up images of Didymos
Commentary:
Kinetic deflection moves from a one-shot impact demo to a close-up crash-site investigation with falsifiable models.
2. Poland’s Orbital Matter: first structure 3D-printed in open space (~30 cm boom) (in-space manufacturing)
Summary:
ESA reported on November 11 that Orbital Matter’s printer on the Replicator 2 satellite built a hollow boom about 32.5 cm long and 3.8 cm in diameter in roughly 30 minutes under open-space extremes. The Rubik’s-cube-scale printer sat beneath a stowed solar array so the extending boom could push the array open, confirming success. Prior additive-manufacturing milestones occurred in controlled cabin, suborbital, or otherwise sheltered settings (ISS polymers, DLR suborbital metals, ESA’s 2024 on-orbit metals). ESA materials leads called the demo a step toward sustainable, self-sufficient in-space manufacturing.
Links:
Commentary:
Moving printers from pressurized labs into vacuum and thermal cycling is what turns in-space construction from demo to infrastructure.
3. Independent imaging reconfirms the M87* black-hole shadow: ring ~42.2±1.5 μas (gravity physics)
Summary:
An Australia-led team published on November 11 in Nature an independent interferometric imaging method—free of strong morphological priors and built on observables robust to calibration errors—applied to Event Horizon Telescope data on M87*. The reconstructions unequivocally recover a ring-like shadow with angular diameter 42.2±1.5 microarcseconds, corresponding to about 6.5±0.5 billion solar masses under nominal scaling. High-quality epochs from 2017, 2018, and 2021 yield compact ~40 μas rings brightened south/southwest at ~20° inclination. The result answers critiques since 2022 that the original ring was a reconstruction artefact and largely corroborates the 2019 EHT image.
Links:
- Nature — Independent interferometric observable confirms black hole shadow in M87*
- Nature News — Iconic first image of black hole holds up to scrutiny
Commentary:
When an independent observable reproduces the ring, the black-hole shadow graduates from iconic picture to testable physics.
II. Biomedicine & Health
4. DeepMind launches AlphaGenome 2: predicting DNA-variant effects across hundreds of cell types (genomic AI)
Summary:
On November 11, Google DeepMind announced AlphaGenome 2, trained on more than 100 million single-cell profiles across 68 tissues to turn static cell atlases into a predictive engine for human genetics. Versus prior tools, it nearly doubles the share of expression-altering causal variants recovered on TenK10K-style benchmarks (~30% vs 16%) and improves directional gene-effect calls; it also computationally recapitulates the IBD finding that a distant ETS2 regulatory variant acts in gut macrophages. The AlphaGenome API is open for non-commercial research, with commercial private preview; the models are research-only and not clinically validated. Nature noted the model reproduced aspects of a complex genetics discovery without wet-lab pipetting.
Links:
Commentary:
Cell-type-specific variant effects shift from multi-year wet-lab campaigns toward a queryable hypothesis engine at single-cell resolution.
5. Gladstone: blood–brain barrier stops importing protective proteins early in Alzheimer’s mouse models (neurodegeneration)
Summary:
On November 11 in Cell, Andrew Yang’s Gladstone team mapped plasma proteins that cross the mouse blood–brain barrier: of 861 labeled proteins, 92 entered the brain, many from distant organs such as the liver. Liver-derived APOA1 reaches astrocytes and triggers cholesterol release needed for synapses. In Alzheimer’s-like mice, the barrier ceases importing APOA1 and other protective proteins before it becomes leaky, coinciding with synapse loss and behavioral changes; boosting hepatic APOA1 raised brain levels and eased some disease markers. The authors argue Alzheimer’s may begin when the brain’s bodily supply line fails; human generalizability remains unproven.
Links:
- Gladstone Institutes — Study rewrites the rules of the blood-brain barrier
- Nature — New culprit in early Alzheimer’s: BBB blocks protective proteins
Commentary:
Recasting the BBB as active logistics—not just a leak wall—points Alzheimer’s early intervention toward restoring peripheral supply lines.
6. enGene: detalimogene pivotal cohort hits 56% complete response; BLA to start by year-end (bladder cancer gene therapy)
Summary:
On November 11, enGene Therapeutics updated pivotal Cohort 1 of the Phase 2 LEGEND trial in BCG-unresponsive high-risk NMIBC with CIS: among 120 efficacy-evaluable patients (125 enrolled), complete response at any time rose to 56% from 54% in the April 2026 cut; preliminary median duration of response is 10.1 months, landmark 12-month CR 24%, and Kaplan–Meier DoR ≥12 months 43%. About 97% of evaluable patients remained free of progression to muscle-invasive or metastatic disease, and 86% avoided cystectomy; serious treatment-related adverse events occurred in ~2%. After FDA pre-BLA alignment on the efficacy population, the company plans to start the BLA by end-2026 and finish in H1 2027—positioning detalimogene as a non-viral plasmid gene therapy usable in routine urology settings if approved.
Links:
Commentary:
For BCG-unresponsive NMIBC, a non-viral gene therapy that can fit community urology practice matters as much as the response rate itself.
7. Manchester and the Institute for Protein Design: AI-designed enzymes for a lenacapavir amide step (biocatalysis)
Summary:
The University of Manchester reported on November 11 that, with Gates Foundation support and the UW Institute for Protein Design, it used the RFD4-Proteina generative model to design de novo amide ligases for a hard amide-bond step in synthesizing the long-acting HIV prevention drug lenacapavir. Of 67 designs tested, four showed clear activity; the best converted ~79% of the starting amine with high S-enantiomer selectivity. Earlier directed evolution of an aminotransferase screened >12,000 variants to >98% conversion, 90% isolated yield, and 99.5% enantiomeric purity for a chiral amine intermediate. Related work appears on bioRxiv (11 Nov 2026) and in JACS, aiming to cut manufacturing cost for global access.
Links:
Commentary:
Compressing enzyme discovery from tens of thousands of variants to dozens of computed candidates is how generative design attacks global-health cost bottlenecks.
III. Climate & Environment
8. Potsdam Institute: without land-sector mitigation, 1.5°C is out of reach this century (land–energy trade-offs)
Summary:
A PIK team published on November 11 in Nature Sustainability REMIND–MAgPIE pathways under varied AFOLU policy portfolios. Without substantial land-based mitigation, limiting warming to 1.5°C by 2100 after a temporary overshoot is unachievable. To keep peak warming below 1.7°C with a global carbon price alone, the 2040 price would need ~$400/t and 2025–2100 consumption loss ~3.5% versus baseline; full land-sector mobilisation cuts those figures to ~$130/t and ~1.3%. The authors recommend a balanced mix: residual biomass energy, total bioenergy capped near 100 EJ/yr, CH₄ and N₂O pricing capped around $75/tCO₂e, plus strong global forest protection.
Links:
- Nature Sustainability — Cost-effective climate change mitigation through land sector contributions
- PIK — Why land is so important for climate protection
Commentary:
In the climate arithmetic, land is not an optional bonus—without it, the energy transition’s price tag becomes socially unaffordable.
9. SUSTech: atmospheric CO₂ growth–land carbon sink coupling strengthened over six decades (carbon cycle)
Summary:
On November 11, Zhenzhong Zeng’s team at Southern University of Science and Technology highlighted a Nature Geoscience study combining 1959–2022 atmospheric CO₂ growth-rate records with inversion and dynamic vegetation model land-sink estimates. The negative correlation between detrended CO₂ growth and land-sink anomalies has strengthened over six decades. Regional contributions reorganized: tropics increasingly reinforce the global anticorrelation, while high latitudes often flip sign; in CarboScope, the land-area fraction reinforcing the anticorrelation rose from about 78.1% to 82.7%. The authors stress the coupling is time-dependent, so recent observational constraints may not transfer cleanly to earlier periods or future climates.
Links:
Commentary:
As land sinks increasingly dominate year-to-year CO₂ swings, extrapolating modern couplings backward or forward risks systematic bias.
10. Nature: chordwise-flexible rubber tidal blades passively cut fatigue loads by up to one-third (ocean energy)
Summary:
An Edinburgh-led team published on November 11 in Nature flexible rubber tidal-turbine blades with chordwise trailing-edge deformation. Across simulated tidal cycles they matched the total energy yield of rigid blades with active pitch control while cutting high-frequency fatigue-inducing load fluctuations by up to one-third. Aeroelastic flattening of camber under load provides passive regulation without underwater sensors and actuators. Europe’s tidal resource is estimated near 50 TWh/yr and the U.S. near 220 TWh/yr, but harsh hydrodynamics drive capital and maintenance costs; passive flexible blades offer a path to lower LCOE.
Links:
Commentary:
Tidal power’s bottleneck is underwater mechanical reliability—replacing pitch motors with material flex designs failure points out of the system.
IV. Fundamental Research & Materials
11. MIT and Barabási teams: scale-rich metamaterials turn network heterogeneity into tunable impact absorption (mechanical metamaterials)
Summary:
MIT and Albert-László Barabási’s group published an open-access Nature paper on November 11 introducing “scale-rich” metamaterials that embed network-science multiscale heterogeneity into mechanical architectures—ligament lengths, thicknesses, and connectivity spanning orders of magnitude under just two control parameters. Simulations and experiments show far wider tunable elastic anisotropy (~190-fold across densities in the report), more delocalized nonlinear deformation with high energy absorption, stronger dynamic dissipation, and programmable elastic-wave control versus conventional single-scale lattices. MIT News highlights applications in helmets, packaging, armor, and acoustic lenses.
Links:
Commentary:
Metamaterials finally leave the unit-cell photocopier behind, writing internet-like heterogeneity into mechanical skeletons.
12. Penn Engineering: cell-membrane-inspired coating speeds organic electrochemical transistors ~67× (bioelectronics)
Summary:
Yuanwen Jiang’s Penn Engineering team with partners in Taiwan, Drexel, and Rutgers described on November 11 Nature Materials work on a cell-membrane-inspired layer for organic electrochemical transistors that reconciles speed and wet stability. Device response fell from ~87 μs to ~1.3 μs (~67× faster); swelling dropped from ~247% to 19%; devices retained ~96% of initial current after four weeks versus ~59% unmodified and ran stably up to 28 days in simulated physiology. In an animal model implanted in a reward-related brain region, modified transistors tracked rapid dopamine signals with reproducible measurements over seven days. The authors stress long-term safety, biofouling, and system integration remain before human use.
Links:
Commentary:
Restricting water made devices faster—showing the bottleneck is often a swollen semiconductor scaffold, not sluggish ions.
Today's Summary
- ESA’s Hera begins close-range “crash-site” science at Didymos, closing the loop on kinetic asteroid deflection.
- AlphaGenome 2 and a blood–brain-barrier protein atlas landed the same day, upgrading disease tools from genomic prediction and brain–body logistics alike.
- Land-sector mitigation was quantified as necessary for 1.5°C; flexible tidal blades and scale-rich metamaterials point to tougher clean-energy and protective hardware.
- Open-space 3D printing and an independently confirmed M87* shadow widen the credible frontier of in-orbit manufacturing and extreme-gravity observation.
Daily Framing:
A planetary-defence closure and cross-scale tools day—asteroid rendezvous, cell-resolved genomic models, and land–energy climate trade-offs all pushed “can we?” toward “can we test and deploy?”
This digest is compiled from real-time search results and is for reference only.